Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma
Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page
- Check3 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page. This appears to be a backend/metadata update with no impact on study details or user-facing features.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded a glossary display and updated QC-related metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; older variants and different capitalization (e.g., 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data') were removed or reformatted.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check46 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link has been removed and Revision: v3.3.2 was deleted.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study. Updated the revision to v3.3.2 and removed the v3.2.0 PubMed note.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoved the government funding/operating status notice from the page footer.SummaryDifference0.5%

Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.